Variation in CYP2A6 Activity and Personalized Medicine.
Variation in CYP2A6 Activity and Personalized Medicine.
复制标题
DOI:
10.3390/jpm7040018
复制
发表时间:
2017-12-01
影响因子:
--
通讯作者:
Tyndale RF
中科院分区:
文献类型:
--
作者:
Tanner JA;Tyndale RF
The cytochrome P450 2A6 (CYP2A6) enzyme metabolizes several clinically relevant substrates, including nicotine—the primary psychoactive component in cigarette smoke. The gene that encodes the CYP2A6 enzyme is highly polymorphic, resulting in extensive interindividual variation in CYP2A6 enzyme activity and the rate of metabolism of nicotine and other CYP2A6 substrates including cotinine, tegafur, letrozole, efavirenz, valproic acid, pilocarpine, artemisinin, artesunate, SM-12502, caffeine, and tyrosol. CYP2A6 expression and activity are also impacted by non-genetic factors, including induction or inhibition by pharmacological, endogenous, and dietary substances, as well as age-related changes, or interactions with other hepatic enzymes, co-enzymes, and co-factors. As variation in CYP2A6 activity is associated with smoking behavior, smoking cessation, tobacco-related lung cancer risk, and with altered metabolism and resulting clinical responses for several therapeutics, CYP2A6 expression and enzyme activity is an important clinical consideration. This review will discuss sources of variation in CYP2A6 enzyme activity, with a focus on the impact of CYP2A6 genetic variation on metabolism of the CYP2A6 substrates.
登录
查看更多内容
DOI:
10.1093/jnci/94.2.108
发表时间:
2002-01-16
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
Benowitz, NL;Pérez-Stable, EJ;Jacob, P
通讯作者:
Jacob, P
影响因子:
6.7
作者:
BENOWITZ, NL;JACOB, P
通讯作者:
JACOB, P
影响因子:
6
作者:
Chen, Li-Shiun;Bloom, A. Joseph;Bierut, Laura
通讯作者:
Bierut, Laura
影响因子:
6.7
作者:
Dempsey, D;Tutka, P;Benowitz, NL
通讯作者:
Benowitz, NL
DOI:
10.1016/j.ijantimicag.2015.11.012
发表时间:
2016-02-01
影响因子:
10.8
作者:
Cusato, Jessica;Tomasello, Cristina;D'Avolio, Antonio
通讯作者:
D'Avolio, Antonio